PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

计划入组 847 人 · 首次发布于 2009 年 6 月 1 日

Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury

计划入组 9 人 · 首次发布于 2019 年 8 月 9 日

Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD

计划入组 40 人 · 首次发布于 2015 年 2 月 6 日

Bevacizumab(Avastin, Mvasi, Oyavas, Alymsys, Aybintio, Abevmy, Vegzelma, Onbevzi, Zirabev, Lytenava, Avzivi, Lextemy, Ipique)

Rx

Vascular endothelial growth factor gene therapy (ViroMed)

Olinvacimab

Canopy Growth Corporation

Canada

Seritage Growth Properties

United States

CTO Realty Growth

United States

Real-World Study Affirms Long-Term Benefits of Anti-VEGF Therapy for Neovascular AMD

Zhaoke Ophthalmology's TAB014 Meets Primary Endpoint in Phase III wAMD Trial

Advancements in Immune Checkpoint Inhibition for Hepatocellular Carcinoma Treatment